NOVOLOG (INSULIN ASPART)
NOVOLOG (INSULIN ASPART) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: NOVOLOG; Generic name: INSULIN ASPART; Drug class: Insulin Analog [EPC].
| Brand name | NOVOLOG |
|---|---|
| Generic name | INSULIN ASPART |
| Drug class | Insulin Analog [EPC] |
| Manufacturer | A-S Medication Solutions |
| Used for | 1 INDICATIONS AND USAGE NOVOLOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. NOVOLOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION See Full Prescribing Information for important preparation, administration, and dosage instructions ( 2.1, 2.2, 2.3, 2.4, 2.5 ). • Subcutaneous injection ( 2.2 ): o Inject subcutaneously within 5-10 minutes before a meal into the abdominal area, thigh, buttocks or upper arm. o Rotate injection sites within the same region from one injection to the next to reduce risk of lipodystrophy and localized cutaneous amyloidosis. o Should generally be used in regimens with an i |
| Active ingredient(s) | INSULIN ASPART |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13891e5a-e57a-46e8-911c-2f680352b52b |